Hiroyuki Suzuki1, Kento Kannaka1, Tomoya Uehara1

  • 1Laboratory of Molecular Imaging and Radiotherapy, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.

概括

研究人员正在改进放射性标记抗体,用于核医学成像和治疗. 新的策略提高了体内稳定性和生物分布,克服了更好的临床应用的局限性.